Market News (Page 13) - TendieTensor

Market News Page 13 of 278 • 6,944 articles

Corcept Therapeutics (CORT) Faces Investor Scrutiny Amid Receipt of FDA Complete Response Letter For Relacorilant, Shares Tank 50% – Hagens Berman

GlobeNewswire Inc. • Hagens Berman

Corcept Therapeutics (CORT) Faces Investor Scrutiny Amid Receipt of FDA Complete Response Letter For Relacorilant, Shares Tank 50% – Hagens Berman

01/07/2026 05:58 PM • Corcept Therapeutics (CORT) shares plummeted 50% on December 31, 2025, after the company received an FDA Complete Response Letter for relacorilant, indicating the FDA requires additional evidence of effectiveness for the hypercortisolism treatment. The sharp decline wiped out $3.6 billion in market capitalization, prompting a shareholder rights investigation into whether the company misled investors about the drug's efficacy and commercial prospects.

MERpK - Berkshire reduced its position by 6%, indicating a modest portfolio adjustment without strong negative or positive signals
CORT - The company received an FDA Complete Response Letter rejecting its drug application, resulting in a 50% stock price decline and $3.6 billion market cap loss. The investigation suggests potential investor misrepresentation regarding drug efficacy and commercial growth prospects.

#FDA Complete Response Letter #relacorilant #hypercortisolism #Cushing's syndrome #drug approval #shareholder investigation #stock decline #investor losses

Vornado Acquires 3 East 54th Street, a Premier Plaza District Development Site

Benzinga • Globe Newswire

Vornado Acquires 3 East 54th Street, a Premier Plaza District Development Site

01/07/2026 05:57 PM • Vornado Realty Trust (NYSE:VNO) announced the acquisition of 3 East 54th Street in Manhattan's Plaza District for $141 million. The 18,400 square-foot demolition-ready site, located between Fifth and Madison Avenues near the St. Regis Hotel, is zoned for approximately 232,500 buildable square feet. Vornado acquired the property's mortgage in 2024-2025, with the $107 million loan balance credited toward the purchase price. The acquisition complements Vornado's existing nearby holdings in the Plaza District and Park Avenue.

VRSN - Berkshire sold 32% of shares to maintain ownership below 10%, with the sale aligned with previously announced intentions
VNO - The acquisition of a prime Manhattan development site in a prestigious location (Plaza District between Fifth and Madison Avenues) with significant buildable square footage (232,500 sq ft) represents strategic expansion of Vornado's high-value real estate portfolio. The favorable financing structure, where the existing mortgage was credited toward the purchase price, demonstrates operational efficiency and value creation for the company.

#real estate acquisition #Manhattan development #Plaza District #commercial real estate #REIT #property development

GlobeNewswire Inc. • Na

Vornado Acquires 3 East 54th Street, a Premier Plaza District Development Site

01/07/2026 05:57 PM • Vornado Realty Trust announced the acquisition of 3 East 54th Street, a demolition-ready property on 18,400 square feet of land in Manhattan, for $141 million. The company acquired the mortgage on the property in 2024-2025 with a loan balance of $107 million, which was credited toward the purchase price. The site is zoned for approximately 232,500 buildable square feet and complements Vornado's existing Park Avenue and Fifth Avenue holdings.

VNO - The acquisition of a prime Manhattan property in a strategic location adjacent to the St. Regis Hotel and complementing existing high-value holdings demonstrates active portfolio expansion and development opportunities. The company's ability to convert a mortgage into an acquisition with significant buildable square feet (232,500 sq ft) indicates strong strategic positioning and growth potential in a premium real estate market.

#real estate acquisition #Manhattan property #demolition-ready asset #Upper Fifth Avenue #development opportunity #REIT

QURE Investigation: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the Firm

GlobeNewswire Inc. • Kessler Topaz Meltzer & Check, Llp

QURE Investigation: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the Firm

01/07/2026 05:56 PM • Law firm Kessler Topaz Meltzer & Check is investigating potential securities law violations by uniQure N.V. after the FDA rejected sufficient evidence for the company's AMT-130 gene therapy BLA submission on November 3, 2025. The announcement caused uniQure's stock to plummet over 50%, falling from $67.69 to $34.29. The firm is encouraging affected investors to contact them regarding the potential class action lawsuit.

JPM - Participating as lead bank in a standard syndicated loan arrangement without exceptional risks or opportunities
QURE - FDA rejected sufficient evidence for AMT-130 BLA submission, causing stock to fall over 50% in a single day. The company faces regulatory setback, unclear timeline for product approval, and potential securities litigation.

#securities fraud #FDA rejection #gene therapy #class action lawsuit #stock price decline #BLA submission #Huntington's disease

LRN 5-DAY DEADLINE ALERT: Stride (LRN) Investors Encouraged to Contact Hagens Berman, Securities Class Action Pending Over Alleged Undisclosed Operational Failures

GlobeNewswire Inc. • Hagens Berman

LRN 5-DAY DEADLINE ALERT: Stride (LRN) Investors Encouraged to Contact Hagens Berman, Securities Class Action Pending Over Alleged Undisclosed Operational Failures

01/07/2026 05:51 PM • Hagens Berman has filed a securities class action lawsuit against Stride, Inc. (LRN) alleging the company inflated enrollment figures using 'Ghost Students' and concealed a catastrophic technology platform failure. The undisclosed operational failures led to a 54% single-day stock crash, with the company forced to slash growth forecasts from 19% to 5%. The lead plaintiff deadline is January 12, 2026.

JPMpC - Participating as lead bank in a standard syndicated loan arrangement without exceptional risks or opportunities
LRN - The company is accused of systematic fraud involving inflated enrollment metrics, concealment of known technology failures, and misleading investors about operational stability. These allegations resulted in a 54% stock crash and billions in market capitalization loss, indicating severe reputational and financial damage.

#securities fraud #class action lawsuit #enrollment inflation #Ghost Students #technology platform failure #stock crash #operational failures #misrepresentation

Vornado Prices Public Offering of $500 Million of 7-Year Bonds

GlobeNewswire Inc. • Na

Vornado Prices Public Offering of $500 Million of 7-Year Bonds

01/07/2026 05:49 PM • Vornado Realty Trust announced the pricing of a $500 million offering of 5.75% senior unsecured notes due February 1, 2033, at 99.824% of face value. The net proceeds of approximately $494 million will be used to repay $400 million of unsecured notes due June 1, 2026, with the remainder allocated for general corporate purposes. The offering is expected to close on January 14, 2026.

JPMpD - Participating as lead bank in a standard syndicated loan arrangement without exceptional risks or opportunities
VNO - The company is executing a standard refinancing strategy to manage debt maturities. While refinancing at 5.78% yield reflects current market conditions and interest rate environment, the transaction itself is a routine capital management activity with no indication of financial distress or exceptional opportunity. The pricing at 99.824% is close to par, suggesting normal market conditions.

#debt refinancing #senior unsecured notes #bond offering #maturity extension #real estate investment trust

Correction: Transactions of Managers and Closely Associated Persons

GlobeNewswire Inc. • Na

Correction: Transactions of Managers and Closely Associated Persons

01/07/2026 05:00 PM • ATP Holdings ehf. disclosed two transactions in Alvotech shares with the Luxembourg CSSF: an acquisition of 4,812,257 shares on December 17, 2025, and a sale of 2,110,640 shares on December 19, 2025, both at SEK 44.06 per share. The original announcement from January 6, 2025, incorrectly labeled the December 19 transaction as an acquisition rather than a sale.

BACpN - Berkshire reduced its position by 6%, indicating a modest portfolio adjustment without strong negative or positive signals
ALVO - The article reports routine regulatory filings of insider transactions without indicating any material business developments, financial performance changes, or strategic implications. The transactions are factual disclosures required by regulatory compliance.

#ATP Holdings ehf. #Alvotech #share acquisition #share sale #CSSF filing #manager transactions

SAVE THE DATE: NOVAGOLD 2025 Year-End Report, Conference Call and Video Webcast

GlobeNewswire Inc. • Na

SAVE THE DATE: NOVAGOLD 2025 Year-End Report, Conference Call and Video Webcast

01/07/2026 05:00 PM • NOVAGOLD Resources announced strong results from its 2025 Donlin Gold drill program, delivering high-grade gold intercepts across multiple zones with values up to 26.22 g/t. The company also received a positive decision from the Alaska Supreme Court. Management will discuss these developments and progress toward the Bankable Feasibility Study during a conference call on January 22, 2026.

BACpM - Berkshire reduced its position by 6%, indicating a modest portfolio adjustment without strong negative or positive signals
NG - The company reported high-grade gold intercepts from its 2025 drill program and received a positive legal decision from the Alaska Supreme Court, both of which are favorable developments for project advancement and de-risking. These results support progress toward the Bankable Feasibility Study.

#Donlin Gold #high-grade drill results #Alaska Supreme Court #Bankable Feasibility Study #gold exploration #drill program

Leiðrétting: Viðskipti stjórnenda og tengdra aðila

GlobeNewswire Inc. • Benedikt Stefánsson

Leiðrétting: Viðskipti stjórnenda og tengdra aðila

01/07/2026 05:00 PM • ATP Holdings ehf. reported transactions in Alvotech shares to Luxembourg's financial regulator CSSF, including the purchase of 4.812.257 shares on December 17 and the sale of 2.110.640 shares on December 19, both at 44.06 SEK per share. A correction was issued regarding the December 19 transaction classification.

BACpL - Berkshire reduced its position by 6%, indicating a modest portfolio adjustment without strong negative or positive signals
ALVO - The article reports routine insider transactions filed with regulatory authorities. The mixed buy and sell activity by a related party does not indicate positive or negative sentiment about the company's prospects, but rather represents standard regulatory disclosure of manager transactions.

#insider trading #stock transactions #CSSF filing #Alvotech #ATP Holdings #manager transactions

California Water Service Group Promotes Todd K. Peters and Thomas A. Scanlon

GlobeNewswire Inc. • Not Specified

California Water Service Group Promotes Todd K. Peters and Thomas A. Scanlon

01/07/2026 05:00 PM • California Water Service Group promoted Todd K. Peters to Vice President of Engineering and Thomas A. Scanlon to Vice President of Corporate Controller and Chief Accounting Officer, effective January 1, 2026. Both executives bring decades of combined experience to their new roles at the water utility company serving over 2.1 million people across five states.

BACpK - Berkshire reduced its position by 6%, indicating a modest portfolio adjustment without strong negative or positive signals
CWT - The promotion of two experienced executives with strong track records (Peters with 33 years tenure and Scanlon with 16 years) demonstrates organizational stability and confidence in internal talent development. CEO's endorsement of their contributions and achievements suggests positive momentum in company leadership.

#executive promotion #Vice President Engineering #Chief Accounting Officer #California Water Service Group #leadership #water utility

Celestica Q4 2025 Financial Results and Conference Call Thursday, January 29, 2026

GlobeNewswire Inc. • Na

Celestica Q4 2025 Financial Results and Conference Call Thursday, January 29, 2026

01/07/2026 04:45 PM • Celestica Inc. announced it will release its fourth quarter 2025 financial results on January 28, 2026, with a conference call on January 29, 2026. The company also introduced its SD6300 Platform designed to deliver maximum storage density for enterprise and AI applications, and announced acceptance of a Normal Course Issuer Bid by the TSX.

BACpO - Berkshire reduced its position by 6%, indicating a modest portfolio adjustment without strong negative or positive signals
CLS - The company is launching innovative storage solutions (SD6300 Platform) targeting high-growth AI and enterprise markets, demonstrating product development momentum. Additionally, the TSX acceptance of a Normal Course Issuer Bid indicates management confidence in the company's valuation and financial position.

#Celestica #Q4 2025 financial results #SD6300 Platform #storage density #AI applications #data center infrastructure #Normal Course Issuer Bid #share buyback

Netflix Stock Has A January Superpower — And The Numbers Prove It

Benzinga • Piero Cingari

Netflix Stock Has A January Superpower — And The Numbers Prove It

01/07/2026 04:39 PM • Netflix has demonstrated a striking seasonal pattern over the past two decades, with January being its strongest month historically. The stock has averaged a 14.7% gain in January, finishing higher in 71% of years—significantly outperforming the S&P 500 and tech peers. This strength is attributed to peak holiday viewing driving subscriber engagement and positive fourth-quarter earnings reports that typically exceed expectations. Netflix is set to report Q4 2025 results on January 20, 2026.

BACpP - Berkshire reduced its position by 6%, indicating a modest portfolio adjustment without strong negative or positive signals
NFLX - Netflix exhibits a strong historical January seasonal pattern with an average 14.7% gain and 71% win rate over two decades. The article highlights consistent outperformance during this period driven by peak holiday engagement and typically positive earnings surprises, though it notes this pattern is not guaranteed.

#seasonal pattern #January performance #Netflix earnings #subscriber growth #streaming #fourth-quarter results #holiday viewing

Better Energy Stock: ExxonMobil vs. Cameco

The Motley Fool • Courtney Carlsen

Better Energy Stock: ExxonMobil vs. Cameco

01/07/2026 04:35 PM • The article compares two energy stocks with different growth trajectories. Cameco, a uranium miner, benefits from nuclear energy expansion but trades at an expensive 65x forward earnings valuation. ExxonMobil, an integrated oil and gas company, offers better value at 17x forward earnings with opportunities in natural gas and LNG, making it more suitable for value investors.

BMLpG - Berkshire reduced its position by 6%, indicating a modest portfolio adjustment without strong negative or positive signals
CCJ - Strong long-term growth opportunity from nuclear energy expansion and tripling of global nuclear capacity by 2050. Stock has surged 80% recently. However, sentiment is tempered by expensive valuation at 65x forward earnings, making it suitable only for growth-oriented investors.

#energy stocks #nuclear energy #uranium mining #natural gas #LNG #valuation #data centers #AI demand

Park Dental Partners Completes Acquisitions of Two Practices - Enters Phoenix Market and Expands Twin Cities Presence

Benzinga • Globe Newswire

Park Dental Partners Completes Acquisitions of Two Practices - Enters Phoenix Market and Expands Twin Cities Presence

01/07/2026 04:35 PM • Park Dental Partners (NASDAQ:PARK) announced the completion of two dental practice acquisitions on December 31, 2025: Sunlight Dental in Phoenix, Arizona, and Weddell Dental in Bloomington, Minnesota. The acquisitions mark the company's entry into its third state and strengthen its presence in the Twin Cities, adding two doctors and 11 team members to its network of 87 practice locations.

BACpS - Berkshire reduced its position by 6%, indicating a modest portfolio adjustment without strong negative or positive signals
PARK - The company successfully completed two strategic acquisitions that expand its geographic footprint into a new state (Arizona) and strengthen its existing presence in Minnesota. The acquisitions align with the company's disciplined growth strategy and add quality practices with experienced clinicians, supporting the company's mission-driven network expansion.

#dental practice acquisitions #geographic expansion #Phoenix market entry #Twin Cities expansion #M&A activity #healthcare consolidation

GlobeNewswire Inc. • Na

Park Dental Partners Completes Acquisitions of Two Practices - Enters Phoenix Market and Expands Twin Cities Presence

01/07/2026 04:35 PM • Park Dental Partners (NASDAQ: PARK) completed acquisitions of Sunlight Dental in Phoenix, Arizona, and Weddell Dental in Bloomington, Minnesota on December 31, 2025. The deals mark the company's entry into its third state and represent its 47th practice in the Twin Cities. The acquisitions add two doctors and 11 team members to the network, which now operates 87 practice locations with over 200 dentists.

BACpQ - Berkshire reduced its position by 6%, indicating a modest portfolio adjustment without strong negative or positive signals
PARK - The company successfully completed strategic acquisitions that expand its geographic footprint into a new state (Arizona) and strengthen its presence in existing markets (Minnesota). The deals align with the company's disciplined growth strategy and add quality practices led by experienced clinicians, demonstrating successful execution of expansion plans.

#dental practice acquisition #geographic expansion #Phoenix market entry #Twin Cities expansion #general dentistry #practice consolidation

The Motley Fool • Eric Volkman

Why UniFirst Stock Tumbled by 3% Today

01/07/2026 04:32 PM • UniFirst's stock fell 3% following its Q1 fiscal 2026 earnings report. While the company beat revenue expectations at $621 million (nearly 3% YoY growth), it missed on earnings with $1.89 per share versus analyst estimates of $2.10. Net income declined 20% due to investment activities. The company reaffirmed its full-year guidance but forecasted a notable decline in annual earnings compared to 2025, which failed to inspire investor confidence.

BMLpH - Berkshire reduced its position by 6%, indicating a modest portfolio adjustment without strong negative or positive signals
UNF - Stock declined 3% following earnings report. While revenue beat analyst expectations, the company significantly missed on earnings per share ($1.89 vs. $2.10 expected). Net income fell 20% YoY due to investment activities. Full-year earnings guidance forecasts a notable decline compared to prior year, indicating weakening profitability outlook despite revenue growth.

#earnings miss #revenue beat #profitability decline #investment spending #guidance reaffirmed #workplace uniforms #protective equipment

Immuneering Announces Exceptional 64% Overall Survival At 12 Months in First-Line Pancreatic Cancer Patients Treated with Atebimetinib + mGnP

GlobeNewswire Inc. • Na

Immuneering Announces Exceptional 64% Overall Survival At 12 Months in First-Line Pancreatic Cancer Patients Treated with Atebimetinib + mGnP

01/07/2026 04:00 PM • Immuneering Corporation announced positive Phase 2a trial results showing 64% overall survival at 12 months for atebimetinib combined with modified gemcitabine/nab-paclitaxel in first-line pancreatic cancer patients, nearly double the 35% benchmark from standard of care. The company plans to initiate its pivotal Phase 3 trial (MAPKeeper 301) in mid-2026, with FDA and EMA alignment already secured on trial design.

IMRX - The company reported exceptional clinical trial results with 64% 12-month overall survival, nearly double the standard of care benchmark of 35%. The drug demonstrated consistent survival advantages across multiple time points (6, 9, and 12 months), favorable tolerability profile, and the company has secured regulatory alignment for a pivotal Phase 3 trial expected to begin mid-2026, representing significant clinical and commercial progress.

#atebimetinib #pancreatic cancer #overall survival #Phase 2a trial #Phase 3 trial #gemcitabine/nab-paclitaxel #MEK inhibitor #Deep Cyclic Inhibitor #MAPK pathway

Bilan semestriel du contrat de liquidité DBV Technologies avec ODDO BHF

GlobeNewswire Inc. • Dbv Technologies

Bilan semestriel du contrat de liquidité DBV Technologies avec ODDO BHF

01/07/2026 04:00 PM • DBV Technologies released its semi-annual report on its liquidity contract with ODDO BHF as of December 31, 2025. The contract showed 74,580 DBV shares and €527,891.63 in cash available. During the July-December 2025 period, 1,658 buy transactions and 1,867 sell transactions were executed, involving approximately 1.5 million shares bought and 1.6 million shares sold.

CEP - Serving as sole book-running manager for the offering, which is a standard financial service role
DBVT - The company announced positive topline results from its Phase 3 VITESSE trial for VIASKIN peanut patch in children aged 4-7 years with peanut allergies. This represents significant clinical progress for their lead therapeutic candidate, indicating advancement toward potential regulatory approval and commercialization.

#liquidity contract #VIASKIN peanut patch #food allergies #immunotherapy #clinical trials #Phase 3 VITESSE trial

Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF

GlobeNewswire Inc. • Dbv Technologies

Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF

01/07/2026 04:00 PM • DBV Technologies released its half-year liquidity report for the period ending December 31, 2025, showing 74,580 shares and €527,891.63 in the liquidity account with ODDO BHF. The company executed 1,658 buy and 1,867 sales transactions, trading approximately 1.5 million shares on purchases and 1.6 million shares on sales. DBV Technologies continues clinical trials of its Viaskin platform for food allergies, with ongoing Phase 3 VITESSE trial results announced in December 2025.

DBVT - The company announced positive topline results from its Phase 3 VITESSE trial for Viaskin Peanut in December 2025, indicating clinical progress. Active trading volume and maintained liquidity account suggest investor engagement and market activity in the stock.

#liquidity contract #DBV Technologies #Viaskin #food allergies #epicutaneous immunotherapy #Phase 3 trial #peanut allergy

Republic Power Group Limited Announces Receipt of a Bid Deficiency Notice from Nasdaq

GlobeNewswire Inc. • Na

Republic Power Group Limited Announces Receipt of a Bid Deficiency Notice from Nasdaq

01/07/2026 04:00 PM • Republic Power Group Limited (NASDAQ: RPGL) received a notification from NASDAQ on January 5, 2026, that its Class A ordinary shares have traded below the $1.00 minimum bid price for 30 consecutive business days. The company has until July 6, 2026 to regain compliance, with a potential additional 180-day grace period if certain conditions are met. The notification has no immediate effect on the company's listing.

RPGL - The company has failed to meet NASDAQ's minimum bid price requirement of $1.00 per share for 30 consecutive business days, triggering a delisting notice. While there is a 180-day cure period, this indicates significant financial distress and stock price deterioration, posing a material risk to shareholders and the company's continued public listing status.

#NASDAQ delisting notice #minimum bid price requirement #stock price below $1.00 #compliance deadline #reverse stock split #ERP software provider

Amlan International Brings Gut Health and Feed Efficiency Innovation to IPPE 2026

GlobeNewswire Inc. • Not Specified

Amlan International Brings Gut Health and Feed Efficiency Innovation to IPPE 2026

01/07/2026 04:00 PM • Amlan International, a mineral-based feed additive company, will showcase its Varium product at the International Production & Processing Expo 2026 in Atlanta. The product is designed as a natural alternative to antibiotic growth promoters, helping poultry producers maintain feed efficiency and profitability in antibiotic-free production systems. The company will highlight over a decade of research demonstrating improvements in gut health and performance under commercial conditions.

ODC - The company is expanding its market presence at a major industry expo, promoting a well-researched product (Varium) backed by over a decade of research. The messaging emphasizes proven solutions addressing a significant market need (antibiotic-free poultry production), and the company is actively engaging with industry professionals through booth presence and technical presentations, indicating strong market confidence and growth opportunities.

#poultry production #antibiotic-free #feed additives #gut health #feed efficiency #Varium #IPPE 2026 #mineral-based solutions

Pure Cycle Announces Financial Results for the Three Months Ended November 30, 2025

GlobeNewswire Inc. • Na

Pure Cycle Announces Financial Results for the Three Months Ended November 30, 2025

01/07/2026 04:00 PM • Pure Cycle Corporation reported Q1 2026 net income of $4.5 million, a 16% increase year-over-year, marking 26 consecutive quarters of profitability. Revenue grew 59% to $9.1 million, driven by strong land development sales at Sky Ranch Master Planned Community. The company is expanding partnerships with national homebuilders and beginning construction on a charter high school, while maintaining a cash position of $17.1 million.

AXP - Mentioned as a partner supporting the restaurant program without significant commentary
PCYO - Company demonstrated strong financial performance with 16% net income growth, 59% revenue increase, and 26 consecutive quarters of profitability. Land development segment showed significant growth with lot sales revenue increasing 159%. Expansion of homebuilder partnerships (adding Pulte Group and Oakwood) and strategic infrastructure investments (I-70 interchange, charter school) indicate positive momentum and future growth prospects.

#Pure Cycle Corporation #Q1 2026 earnings #net income growth #Sky Ranch Master Planned Community #land development #water and wastewater services #homebuilder partnerships #lot sales revenue

Analyst Says Goldman Sachs CEO David Solomon Faces Key Challenge In Managing Earnings Volatility

Benzinga • Lekha Gupta

Analyst Says Goldman Sachs CEO David Solomon Faces Key Challenge In Managing Earnings Volatility

01/07/2026 03:54 PM • BofA Securities analyst Ebrahim Poonawala raised Goldman Sachs' price target to $1,050 from $900 with a Buy rating, but notes CEO David Solomon's main challenge is managing earnings volatility. The analyst expects a 20% rebound in investment banking revenue for FY26 and normalized performance by FY27, with ROTCE approaching 19% and an efficiency ratio around 60%. Goldman's earnings have historically swung significantly, with a 56% EPS drop from 2021 to 2023, driven by capital markets business volatility.

GOOG - Berkshire took a $4.3 billion position, making it the tenth largest holding. Positive factors include strong AI strategy, accelerating growth across services, and resolution of antitrust lawsuit
GS - Analyst raised price target significantly (from $900 to $1,050), maintained Buy rating, and expects strong FY26 rebound with 20% investment banking revenue growth and normalized performance by FY27. However, sentiment is tempered by acknowledged concerns about earnings volatility inherent in the capital markets business.

#earnings volatility #investment banking #capital markets #price target #EPS growth #trading revenue #financing revenue #M&A #operating efficiency

ROSEN, A LONGSTANDING LAW FIRM, Encourages Bitdeer Technologies Group Investors to Secure Counsel Before Important Deadline in Securities Class Action - BTDR

GlobeNewswire Inc. • Rosen Law Firm

ROSEN, A LONGSTANDING LAW FIRM, Encourages Bitdeer Technologies Group Investors to Secure Counsel Before Important Deadline in Securities Class Action - BTDR

01/07/2026 03:50 PM • Rosen Law Firm is reminding investors who purchased Bitdeer Technologies Group securities between June 6, 2024 and November 10, 2025 of an important February 2, 2026 lead plaintiff deadline in an ongoing securities class action. The lawsuit alleges that Bitdeer provided misleading statements about its SEALMINER A4 Bitcoin mining machine and SEAL04 chip technology, failing to disclose material information about production timelines and energy efficiency specifications, causing investors to purchase securities at artificially inflated prices.

GOOGL - Berkshire took a $4.3 billion position, making it the tenth largest holding. Positive factors include strong AI strategy, accelerating growth across services, and resolution of antitrust lawsuit
BTDR - The company is the subject of a securities class action lawsuit alleging material misstatements and omissions regarding its SEALMINER A4 project and chip technology. Defendants allegedly provided false and misleading information about production timelines and energy efficiency specifications, causing investors to suffer damages from artificially inflated stock prices.

#securities class action #Bitdeer Technologies #SEALMINER A4 #SEAL04 chip #lead plaintiff deadline #material misstatement #Bitcoin mining #investor damages

Defense Stocks Sink After Trump Orders Contractors To Halt Dividends, Buybacks

Benzinga • Piero Cingari

Defense Stocks Sink After Trump Orders Contractors To Halt Dividends, Buybacks

01/07/2026 03:45 PM • President Trump ordered U.S. defense contractors to immediately halt dividend payments and share buybacks, citing underinvestment in production and excessive executive compensation. Trump stated that dividends and buybacks will remain banned until companies build modern production facilities, accelerate equipment output, and improve maintenance quality. He also capped executive compensation at $5 million until production issues are resolved. The announcement triggered sharp declines across the defense sector, with major contractors and aerospace & defense ETFs falling significantly.

BAC - Berkshire reduced its position by 6%, indicating a modest portfolio adjustment without strong negative or positive signals
LMT - Stock declined 4.97% following Trump's order to halt dividends and buybacks. As a major defense contractor, the company faces restrictions on shareholder returns and executive pay, impacting near-term investor returns.

#defense contractors #dividends #share buybacks #production capacity #executive compensation #military equipment #capital allocation